Literature DB >> 8842688

Phenothiazines are potent inhibitors of osteoclastic bone resorption.

T J Hall1, H Nyugen, M Schaeublin, M Michalsky, M Missbach.   

Abstract

1. We have previously shown that promethazine inhibits osteoclastic bone resorption in the in vitro bone slice assay (IC50 = 0.8 microM), but the mechanism(s) involved are unclear. 2. We have now tested the effects on osteoclast activity of five other structurally related compounds. Phenothiazine, chlorpromazine, amitriptyline, phenazine, and phenoxazine had IC50 values of 0.8, 0.9, 6, 7, and > 10 microM, respectively, in the bone slice assay, indicating that the basic phenothiazine structural element itself is important for osteoclast inhibitory activity. 3. The results are discussed in terms of the known effects of phenothiazines on plasma membrane fluidity, blocking of ion channels, and inhibition of calmodulin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8842688     DOI: 10.1016/0306-3623(95)02109-4

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

1.  Characterization of synthesized NANO-encapsulated drug for bone loss on hind limb suspension rat model by NMR and micro-CT.

Authors:  Qingwen Ni; Hong Dixon; Gloria Gutierrez; Long Bi; Yi-Xian Qin
Journal:  Adv Biosci Bioeng (N Y)       Date:  2014-06-14

2.  Mepazine Inhibits RANK-Induced Osteoclastogenesis Independent of Its MALT1 Inhibitory Function.

Authors:  Laura Meloni; Lynn Verstrepen; Marja Kreike; Jens Staal; Yasmine Driege; Inna S Afonina; Rudi Beyaert
Journal:  Molecules       Date:  2018-11-30       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.